A radioimmunoassay for the measurement of gastric inhibitory polypeptide (GIP) in unextracted plasma in man has been developed using a rabbit antiserum raised against porcine GIP. Porcine GIP was employed also as standard and to produce a 1251-labelled tracer. The assay was able to distinguish 110 pgjml GIP from zero in plasma samples. Negligible cross-reactivity was demonstrated with cholecystokinin, insulin, pancreatic polypeptide, glucagon, secretin, and vasoactive intestinal polypeptide. The mean overnight fasting plasma GIP level in 28 normal
subjects was 203 pg/rnl (range: undetectable-420 pg/ml), Plasma GIP levels rose, within 45 minutes of eating a mixed meal, to a mean level of 1573 pg/ml, The existence of a hormone called 'enterogastrone' Material and methods was postulated some 45 years ago to account for the inhibition of gastric acid secretion and delay in gastric emptying that follows ingestion of a fat meal (Kosaka and Lim, 1930) . In 1969 Brown et al. isolated and purified from a crude preparation of porcine cholecystokinin a peptide that had enterogastrone activity (Brown et al., 1969 (Brown et al., , 1970 . It was subsequently renamed 'gastric inhibitory polypeptide' (GIP) because of controversy surrounding PRODUCTION OF ANTISERUM the nature of enterogastrone and the primary action Two 3-month-old half-lop rabbits (high antibody of GIP.
producing strain: Ranch Rabbits Ltd, Crawley The major biological actions of GIP were thought Down, Sussex) were each primed with a conjugate initially to be inhibition of gastrin, pepsin, and containing 95 11-g porcine GIP. The hormone was gastric acid secretion, but, subsequently, its ability coupled to ovalbumin (BDH) by means of the to stimulate insulin secretion by the pancreas, glutaraldehyde condensation technique of Reichlin especially in the presence of hyperglycaemia, aroused et al. (1968) and used without dialysis within one more interest (Brown et al., 1975b) . This is currently hour of preparation. The conjugate was emulsified thought to be its most important biological action with Freund's complete adjuvant (ratio 2 vol oil:l and the one most likely to be physiologically vol water) and injected intradermally (5011-1 emulrelevant. Measurement of circulating GIP levels sion/site) on the backs of the animals at approxicould, therefore, be of importance in clinical condi-mately 60 sites according to the method of tions where insulin secretion is abnormal. Vaitukaitis et al. (1971) . The animals were boosted The radioimmunoassay of GIP has been described intramuscularly after five months with 100 11-g of only once in the literature (Kuzio et al., 1974) , and conjugated GIP and again at seven months with almost all published work on the measurement of 2'5 11-g of unconjugated GIP intravenously. At eight circulating GIP has been performed using an anti-months the animals were reprimed with 100 iLg serum raised by Brown and his colleagues (Kuzio et conjugated GIP as before. Following this regime al., 1974) . The present study describes the production both animals produced antibodies to GIP, one with of an antiserum in rabbits against porcine GIP and a titre of 1:37 000, the other with a titre of 1:25 000 the subsequent development and validation of a ( Fig. 1 ). radioimmunoassay ofsufficient sensitivity to measure All of the work described in this paper was circulating GIP levels in unextracted plasma in man. performed with antiserum obtained from rabbit The values obtained for basal and stimulated GIP RIC 34, bleed no. lIIe, used at an initial dilution of levels are compared with those obtained using the 1:6000. Subsequent bleeds have been shown to give radioimmunoassay developed by Kuzio et al. (1974) . similar results. 
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PREPARATION OF 125 I -L A B E L L E D GIP GIP was iodinated using a modification of the chloramine-T technique described by Kuzio et al. (1974) . Three micrograms GIP were freshly weighed for each iodination and transferred to a plastic AutoAnalyzer cup (Sterilin Ltd), and 50 IJ-I 0'5M phosphate buffer, pH 7'4, was added. The GIP solution was kept in an ice/water bath and stirred with a magnetic flea. The solutions used for all subsequent additions were cooled in an ice/water bath to < 10°C before use. As quickly as possible, and in order, the following were added to the GIP solution: 0'5 mCi 1251-sodium iodide (5 IJ-I) (The Radiochemical Centre, Amersham), 10 IJ-g chloramine-T (5 IJ-l), 37 IJ-g sodium metabisulphite (5 IJ-l), and 100 IJ-g potassium iodide (50 IJ-I). The iodination products were immediately diluted with 100 p.I elution buffer and promptly applied to a 1'1 x 35 ern column of Sephadex G-15 (Pharmacia). They were eluted with 0'2M acetic acid containing 200 KIU aprotinin/rnl (Novo Research Institute, Copenhagen) and 2 %charcoal-stripped serum. Approximately 60 fractions of 500 IJ-l were collected. A single 1251-labelled protein peak was eluted from the column between fractions 20 and 27. Fractions taken from the trailing shoulder of this labelled protein peak retained the greatest immunoreactivity and were used in the radioimmunoassay. The maximum binding of these fractions of 1251_GIP, in the presence of excess antiserum, was approximately 80 %. The specific activity of the labelled protein was calculated, by planimetry, as approximately 80 IJ-Ci/JLg, assuming no loss of protein. The 1251_GIP fractions to be used in the assay were diluted 1: 1 with acid-ethanol (l part concentrated hydrochloric acid in 100 parts absolute ethanol) and stored at -20°C until required.
PREPARATION OF STANDARDS
Porcine GIP was weighed out using a Kahn balance and dissolved in 0'05M acetic acid to a concentration of 10 JLg/ml; 1 JLg aliquots were freeze-dried and stored at -20°C until used. Under these conditions the standard was stable for at least six months.
INCUBATION CONDITIONS
The diluent buffer used in the assay was O'04M phosphate buffer, pH 6'5, containing 500 ()()() KIU aprotinin and 50 g human serum albumin (Blood Products Laboratory, Lister Institute, Elstree) per litre. Charcoal-stripped serum was prepared by pooling serum from normal fasting volunteers and mixing with 20 g charcoal (Norit GSX, Hopkin and Williams) per 100 ml serum overnight at 4°C. The charcoal was removed by centrifugation followed by filtration through 6 em Zeitz filters (Grade HP/EKS obtainable from Carlson-Ford Ltd, Ashton-under-Lyne).
To a series of polystyrene LP3 tubes (Luckhams Ltd) was added 200 JLl assay diluent buffer and either 100 1-' 1 of GIP standards in the range 150-5000 pg/ml diluted in charcoal-stripped serum or 100 1-' 1 plasma sample plus 100 1-' 1 rabbit anti-GIP antiserum at an initial dilution of approximately 1:6000 in assay buffer. Standards and samples were set up in duplicate. A parallel set of tubes was set up without the antiserum to measure non-specific binding, the number of counts being subtracted from the total 1251_GIP bound, when calculating the amount of immunologically active GIP in unknown samples. All the tubes were mixed gently on a Vortex mixer and incubated at 4°C for 24 hours. 100 1-' 1 1251_GIP, diluted in assay buffer so as to contain approximately 5000 cpm/l00 1-'1, was added to every tube. The contents were mixed and the tubes incubated for a further 48 hours at 4°C.
The antibody-bound GIP was separated from the free by a double antibody technique using donkey anti-rabbit gamma globulin antiserum (Guildhay Antisera, University of Surrey, Guildford) at appropriate dilution. After overnight incubation at 4°C the tubes were centrifuged at 2000 g for 20 minutes at 4°C and the supernatant was aspirated. The protein precipitate, containing antibody-bound 1251_GIP, was counted in an automatic y-counter. The amount of immunologically active GIP in unknown or standard tubes was determined by subtracting the number of counts in the corresponding non-specific binding tube. These 'corrected' values were used in the construction of standard curves and in calculating results. .. 
Results

STANDARD CURVE
Under the conditions employed in our assay, increasing quantities of unlabelled GIP displaced 1251_GIP in the range 11-1000 pg (Fig. 2) . Scatchard (1949) analysis of the antiserum gave a binding affinity of 3'5 x 101 0 litres/mole. The sensitivity of the assay, defined as 2 standard deviations of the zero standard (Feldman and Rodbard, 1971) , was 11 pg. Non-specific binding varied with the age of the tracer but was always less than 10%of the added counts.
PRECISION
The intra-assay precision over the standard curve is shown in Figure 2 . The inter-assay precision of two serum samples was also calculated (Table) .
RECOVERY
Two different amounts of porcine GIP were added to a fasting human serum sample containing 125 pg/ml GIP. The recovery of 50 pg added GIP was 95 % and that of 200 pg GIP was 96 %(mean of triplicate estimations).
PARALLELISM
Plasma samples containing a high concentration of endogenous GIP serially diluted in charcoalextracted plasma were superimposable upon the porcine GIP standard curve (Fig. 3) . (Fig. 4) . Negligible cross-reactivity was found when up to 5000 pg of the various peptides was added to the assay tubes.
PLASMA GIP CONCENTRATIONS IN NORMAL
SUBJECTS
Early morning plasma samples were obtained from 28 healthy non-obese subjects after an overnight fast.
The mean GIP concentration was 203 ± 20 pgjml (± SE), the observed range being from undetectable levels up to 420 pg/ml, Five overnight fasted healthy subjects were given a mixed meal consisting of tomato soup (300 rnl), one egg (50 g), bread (18'6 g), butter (7'5 g), and milk (100 mJ). Blood was col1ected before and at 30minute intervals after the beginning of the meal. The plasma GIP concentrations are shown in Figure 5 . ... Two commercial secretin (The Boots Drug Co Ltd P/0014/5242 lot no. 6760) and CCK/PZ preparations (Boots PL/0014/5268 lot no. 6295) were assayed for immunoreactive GIP. In neither was GIP detectable when up to 100 000 pg of each preparation was assayed.
Discussion
The radioimmunoassay for GIP described in this paper has an accuracy, precision, sensitivity, and specificity comparable to, if not better than, the only previously published assay (Kuzio et al., 1974) . Antis.um was raised in rabbits after immunisation with a GIP-ovalbumin conjugate (Fig. 1) . Initially, during the development of the assay, we experienced difficulty in producing an iodinated GIP which retained immunological activity. This led to an underestimation of the titre of the antiserum produced and the subsequent repriming of the rabbits at eight months. Successful iodination of GIP was achieved by lowering the concentration of 126 1, chloramine-T, and sodium rnetabisulphite relative to GIP, shortening the reaction time, and lowering the reaction temperature of the iodination. We were unable to obtain the C-170 neutral charcoal used by Kuzio et al. (1974) for separating antibody-bound from free GIP. Instead we tried Norit GSX, which has been used successfully in the radioimmunoassay of other gut hormones of similar molecular weight. However, we were unable to optimise charcoal concentrations to give effective separation of bound from free 1251_GIP using our antiserum. Separation using second antibody was perfectly satisfactory, however, and gave superior results in terms of both antibody binding and nonspecific binding values compared with charcoal.
It was found necessary to store the GIP standards freeze-dried to prevent deterioration. Solutions of GIP in assay buffer at concentrations of 100 p.g/ml stored at -20°C showed loss of immunological activity within two months.
The anti-GIP antiserum produced by rabbit RIC 34 exhibited a 'plasma effect' necessitating the setting up of standard curves in GIP-free plasma for the direct measurement of GIP in plasma. Because of the relatively low avidity of Norit GSX for GIP, we used a fasting serum pool low in endogenous GIP as the starting material and relatively large quantities of charcoal. Under these conditions GIP was effectively removed. Preliminary work appears to indicate that serum from which immunoreactive GIP has been selectively removed by adsorption with GIP antiserum coupled to Sepharose beads (Alford et al., 1977) is also satisfactory. The use of this material is theoretically preferable to charcoalstripped serum as a standard diluent, because charcoal removes many other low molecular weight Radioimmunoassay ofgastric inhibitory polypeptide substances from serum in addition to GIP and is subject to batch variation.
The GIP values obtained for fasting and postprandial normal subjects are similar to those obtained by others using the previously described GIP assay. Brown et al. (1975a) have described a biphasic response in plasma GIP levels after a mixed meal, with an initial peak at about 45 minutes and a second one two to three hours later. Figure 4 also shows the appearance of two peaks of plasma immunoreactive GIP in a small group of normal subjects after a mixed meal. The first peak occurs 45 minutes and the second between 90 and 120 minutes after ingestion of the meal. The number of subjects in the group is too small, however, for statistical significance to be attached to the results.
The commercial secretin and CCK/PZ preparations obtained from The Boots Drug Co contained negligible amounts of immunoassayable GIP. Kuzio et al. (1974) report that partially purified preparations of CCK/PZ (Gastrointestinal Hormone Research Laboratories) examined by them early on contained approximately 3 % GIP w/w but that later batches contained substantially smaller amounts. It appears from our data that the procedure employed by Boots to prepare secretin and CCK/PZ effectively removes GIP.
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